Application of Metabolomics in Various Types of Diabetes

References

• Carracher AM, Marathe PH, Close KL. International Diabetes Federation 2017. J Diabetes. 2018;10(5):353–356. doi:10.1111/1753-0407.12644
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31.
   Web of Science ®Google Scholar
• Wang Y, Shao T, Wang J, et al. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage. Biomed Pharmacother. 2021;133:110991.
   PubMed Web of Science ®Google Scholar
• Eid S, Sas KM, Abcouwer SF, et al. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019;62(9):1539–1549.
   PubMed Web of Science ®Google Scholar
• Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrino. 2014;2(1):65–75.
   Web of Science ®Google Scholar
• Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol. 2019;20(6):353–367.
   PubMed Web of Science ®Google Scholar
• Borges RM, Colby SM, Das S, et al. Quantum Chemistry Calculations for Metabolomics. Chem Rev. 2021;121(10):5633–5670.
   Web of Science ®Google Scholar
• Wishart DS, Feunang YD, Marcu A, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46(D1):D608–d617. doi:10.1093/nar/gkx1089
   PubMed Web of Science ®Google Scholar
• Milburn MV, Lawton KA. Application of metabolomics to diagnosis of insulin resistance. Annu Rev Med. 2013;64:291–305.
   PubMed Web of Science ®Google Scholar
• Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, Jarmusch AK, Dorrestein PC. Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol. 2022;20(3):143–160.
   Web of Science ®Google Scholar
• Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451–459.
   PubMed Web of Science ®Google Scholar
• Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med. 2009;22(Suppl 3):50–53.
   PubMed Web of Science ®Google Scholar
• Li M, Wang X, Aa J, et al. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol. 2013;304(11):F1317–1324.
   PubMed Web of Science ®Google Scholar
• Perini M, Paolini M, Camin F, et al. Combined use of isotopic fingerprint and metabolomics analysis for the authentication of saw palmetto (Serenoa repens) extracts. Fitoterapia. 2018;127:15–19.
   Web of Science ®Google Scholar
• Trilla-Fuertes L, Gámez-Pozo A, López-Camacho E, et al. Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer. BMC Cancer. 2020;20(1):307.
   Web of Science ®Google Scholar
• Han S, Huang J, Foppiano F, et al. TIGER: technical variation elimination for metabolomics data using ensemble learning architecture. Brief Bioinform. 2022;1:548.
   Google Scholar
• American Diabetes A. 2. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–S33.
   Web of Science ®Google Scholar
• DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449–2462.
   PubMed Web of Science ®Google Scholar
• Pflueger M, Seppänen-Laakso T, Suortti T, et al. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes. 2011;60(11):2740–2747.
   Web of Science ®Google Scholar
• Li Z, Veijola R, Koski E, et al. Childhood Height Growth Rate Association with the Risk of Islet Autoimmunity and Development of Type 1 Diabetes. J Clin Endocrinol Metab. 2022;1:584.
   Google Scholar
• Overgaard AJ, Weir JM, De Souza DP, et al. Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis. Metabolomics. 2016;12(1):13.
   Web of Science ®Google Scholar
• Huff DR, Nunan EL, Gore JL, Wright CL, Valdez C, Butcher JT. Myostatin Deletion Protects Against Renal Dysfunction During a High Salt Diet. FASEB J. 2022;1:45.
   Google Scholar
• Alcazar O, Hernandez LF, Nakayasu ES, et al. Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 Diabetes. Biomolecules. 2021;11:3.
   Web of Science ®Google Scholar
• Devarshi PP, McNabney SM, Henagan TM. Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes. Int J Mol Sci. 2017;18:4.
   Web of Science ®Google Scholar
• Guasch-Ferré M, Hruby A, Toledo E, et al. Metabolomics in Prediabetes and Diabetes: a Systematic Review and Meta-analysis. Diabetes Care. 2016;39(5):833–846.
   PubMed Web of Science ®Google Scholar
• Haythorne E, Rohm M, van de Bunt M, et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic beta-cells. Nat Commun. 2019;10(1):2474.
   Web of Science ®Google Scholar
• Wang-Sattler R, Yu Z, Herder C, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012;8:615.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yan L, Chen W, et al. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal Chim Acta. 2009;650(1):16–22.
   PubMed Web of Science ®Google Scholar
• Athyros VG, Doumas M, Imprialos KP, et al. Diabetes and lipid metabolism. Hormones. 2018;17(1):61–67.
   PubMedGoogle Scholar
• Lee Y, Pamungkas AD, Medriano CAD, et al. High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study. Int J Mol Med. 2018;41(2):1069–1077.
   Web of Science ®Google Scholar
• Li X, Xu Z, Lu X, et al. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: biomarker discovery for diabetes mellitus. Anal Chim Acta. 2009;633(2):257–262.
   PubMed Web of Science ®Google Scholar
• Hooper PL, Balogh G, Rivas E, Kavanagh K, Vigh L. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress Chaperones. 2014;19(4):447–464.
   PubMed Web of Science ®Google Scholar
• Yue S, Yanling L, Likun H, et al. Identification of plasma metabolomic biomarkers in type 2 diabetes. Chin J Hospital Pharm. 2021;41(21):2174–2180.
   Google Scholar
• Visser JT, Bos NA, Harthoorn LF, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev. 2012;28(6):505–513.
   Web of Science ®Google Scholar
• Park JE, Jeong GH, Lee IK, et al. A Pharmacometabolomic Approach to Predict Response to Metformin in Early-Phase Type 2 Diabetes Mellitus Patients. Molecules. 2018;23:7.
   Web of Science ®Google Scholar
• Gu Y, Zhang Y, Shi X, et al. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta. 2010;81(3):766–772.
   PubMed Web of Science ®Google Scholar
• Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16(11):642–653.
   PubMed Web of Science ®Google Scholar
• Crunkhorn S. Type 2 diabetes: targeting glutamine metabolism. Nat Rev Drug Discov. 2018;17(5):316.
   Google Scholar
• Ren W, Xia Y, Chen S, et al. Glutamine Metabolism in Macrophages: a Novel Target for Obesity/Type 2 Diabetes. Adv Nutr. 2019;10(2):321–330.
   Web of Science ®Google Scholar
• Zhang C, Dong L, Wu J, et al. Intervention of resistant starch 3 on type 2 diabetes mellitus and its mechanism based on urine metabonomics by liquid chromatography-tandem mass spectrometry. Biomed Pharmacother. 2020;128:110350.
   Web of Science ®Google Scholar
• Malloy VL, Krajcik RA, Bailey SJ, et al. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell. 2006;5(4):305–314.
   Web of Science ®Google Scholar
• Calabrese V, Dattilo S, Petralia A, et al. Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics. Free Radic Res. 2015;49(5):511–524.
   PubMed Web of Science ®Google Scholar
• Su L, Hong Z, Zhou T, et al. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation. Sci Rep. 2022;12(1):1152.
   Web of Science ®Google Scholar
• Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci. 2021;8(18):e2100275.
   Web of Science ®Google Scholar
• Pirola L, Balcerczyk A, Okabe J, El-Osta A. Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol. 2010;6(12):665–675.
   PubMed Web of Science ®Google Scholar
• Mozzanica F, Ferrulli A, Vujosevic S, et al. Olfactory disfunction and diabetic complications in type 2 diabetic patients: a pilot study. Endocrine. 2022;75(3):760–767.
   Web of Science ®Google Scholar
• Barman S, Srinivasan K. Diabetes and zinc dyshomeostasis: can zinc supplementation mitigate diabetic complications? Crit Rev Food Sci Nutr. 2022;62(4):1046–1061.
   PubMed Web of Science ®Google Scholar
• Gooding J, Cao L, Whitaker C, et al. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy. BMC Nephrol. 2019;20(1):141.
   Web of Science ®Google Scholar
• Arneth B, Arneth R, Shams M. Metabolomics of Type 1 and Type 2 Diabetes. Int J Mol Sci. 2019;20:10.
   Web of Science ®Google Scholar
• Greenman RL, Panasyuk S, Wang X, et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005;366(9498):1711–1717.
   PubMed Web of Science ®Google Scholar
• Barbaro D, Orsini P, Lapi P, Turco A, Pasquini C. Foot bone mass and analysis of calcium metabolism in diabetic patients affected by severe neuropathy. Minerva Endocrinol. 2008;33(4):283–288.
   Web of Science ®Google Scholar
• Jalgaonkar MP, Parmar UM, Kulkarni YA, Oza MJ. SIRT1-FOXOs activity regulates diabetic complications. Pharmacol Res. 2022;175:106014.
   Web of Science ®Google Scholar
• Soleimani Z, Hashemdokht F, Bahmani F, et al. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. J Diabetes Complications. 2017;31(9):1394–1400.
   PubMed Web of Science ®Google Scholar
• Hung SY, Tsai JS, Yeh JT, et al. Amino acids and wound healing in people with limb-threatening diabetic foot ulcers. J Diabetes Complications. 2019;33(10):107403.
   Web of Science ®Google Scholar
• Jones MS, Rivera M, Puccinelli CL, et al. Targeted amino acid supplementation in diabetic foot wounds: pilot data and a review of the literature. Surg Infect (Larchmt). 2014;15(6):708–712.
   Web of Science ®Google Scholar
• Stolle LB, Riegels-Nielsen P. The metabolism of the diabetic foot: in vivo investigation with microdialysis. Acta Orthop Scand. 2004;75(1):106–108.
   PubMed Web of Science ®Google Scholar
• Abbiss H, Maker GL, Trengove RD. Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases. Metabolites. 2019;9:2.
   Web of Science ®Google Scholar
• Gao H, Yu X, Sun R, et al. Quantitative GC-MS assay of citric acid from humans and db/db mice blood serum to assist the diagnosis of diabetic nephropathy. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1077-1078:28–34.
   Web of Science ®Google Scholar
• Harloff M, Prüschenk S, Seifert R, Schlossmann J. Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice. Br J Pharmacol. 2021.
   Web of Science ®Google Scholar
• Fu Y, Sun Y, Wang M, et al. Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism. Cell Metab. 2020;32(6):1052–1062.e1058.
   PubMed Web of Science ®Google Scholar
• Esmati P, Najjar N, Emamgholipour S, et al. Mass spectrometry with derivatization method for concurrent measurement of amino acids and acylcarnitines in plasma of diabetic type 2 patients with diabetic nephropathy. J Diabetes Metab Disord. 2021;20(1):591–599.
   Web of Science ®Google Scholar
• Chen KH, Chen YL, Tang HY, et al. Dietary Leucine Supplement Ameliorates Hepatic Steatosis and Diabetic Nephropathy in db/db Mice. Int J Mol Sci. 2018;19:7.
   Web of Science ®Google Scholar
• Wang Z, Fu W, Huo M, et al. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging. Acta Pharm Sin B. 2021;11(11):3665–3677.
   Web of Science ®Google Scholar
• Pan Q. Diabetic eye disease should be prevented and treated early. Health Med Garden. 2011;1(11):15.
   Google Scholar
• Gale MJ, Scruggs BA, Flaxel CJ. Diabetic eye disease: a review of screening and management recommendations. Clin Exp Ophthalmol. 2021;49(2):128–145.
   Web of Science ®Google Scholar
• Luyuan Z. Research progress of metabolomics in diabetic retinopathy. Chin J Exp Ophthalmol. 2022;40(01):93–96.
   Google Scholar
• Aiello LP, Sun W, Das A, et al. Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med. 2015;372(18):1722–1733.
   Web of Science ®Google Scholar
• McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.
   PubMed Web of Science ®Google Scholar
• Hillier TA, Pedula KL, Ogasawara KK, et al. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. N Engl J Med. 2021;384(10):895–904.
   PubMed Web of Science ®Google Scholar
• Pinto J, Almeida LM, Martins AS, et al. Prediction of Gestational Diabetes through NMR Metabolomics of Maternal Blood. J Proteome Res. 2015;14(6):2696–2706.
   Web of Science ®Google Scholar
• Wu H, Zheng X, Liu Y, et al. Hsa_circRNA_102682 is closely related to lipid metabolism in gestational diabetes mellitus. Gynecol Endocrinol. 2022;38(1):50–54.
   PubMed Web of Science ®Google Scholar
• Furse S, Fernandez-Twinn DS, Beeson JH, et al. A mouse model of gestational diabetes shows dysregulated lipid metabolism post-weaning, after return to euglycaemia. Nutr Diabetes. 2022;12(1):8.
   Web of Science ®Google Scholar
• Miettinen HE, Rönö K, Koivusalo SB, Eriksson JG, Gylling H. Effect of gestational diabetes mellitus on newborn cholesterol metabolism. Atherosclerosis. 2018;275:346–351.
   Web of Science ®Google Scholar
• Sun X, Wang J, Song S, et al.[Metabolomics study on the newborns of pregnant women with gestational diabetes]. Wei Sheng Yan Jiu. 2021;50(3):466–471. Chinese.
   Google Scholar
• Tan B, Ma Y, Zhang L, Li N, Zhang J. The application of metabolomics analysis in the research of gestational diabetes mellitus and preeclampsia. J Obstet Gynaecol Res. 2020;46(8):1310–1318.
   Web of Science ®Google Scholar
• McMichael LE, Heath H, Johnson CM, et al. Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma. Metabolomics. 2021;17(12):105.
   Web of Science ®Google Scholar
• Lai M, Liu Y, Ronnett GV, et al. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: a metabolic profiling study. PLoS Med. 2020;17(5):e1003112.
   PubMed Web of Science ®Google Scholar
• Lowe WL, Scholtens DM, Sandler V, Hayes MG. Genetics of Gestational Diabetes Mellitus and Maternal Metabolism. Curr Diab Rep. 2016;16(2):15.
   PubMed Web of Science ®Google Scholar
• Feng Y, Feng Q, Lv Y, et al. The relationship between iron metabolism, stress hormones, and insulin resistance in gestational diabetes mellitus. Nutr Diabetes. 2020;10(1):17.
   Web of Science ®Google Scholar
• Furse S, White SL, Meek CL, et al. Altered triglyceride and phospholipid metabolism predates the diagnosis of gestational diabetes in obese pregnancy. Mol Omics. 2019;15(6):420–430.
   Web of Science ®Google Scholar
• Lu J, Jiang H, Zhang S, et al. Risk prevention of different forms of gestational diabetes mellitus based on energy metabolism prior to diagnosis. Technol Health Care. 2022.
   Web of Science ®Google Scholar
• Miao M, Dai Y, Rui C, et al. Dietary supplementation of inulin alleviates metabolism disorders in gestational diabetes mellitus mice via RENT/AKT/IRS/GLUT4 pathway. Diabetol Metab Syndr. 2021;13(1):150.
   Web of Science ®Google Scholar